About us

The non-profit German Institute for Cell and Tissue Replacement (DIZG) is a pharmaceutical manufacturer based in Berlin and is one of the largest pharmaceutical and biotechnological non-profit organizations of its kind in Europe.

For over 30 years, we at DIZG have been leading pioneers in the development of innovative human tissue transplants and their widespread clinical availability. Our goal is to enable people with severe tissue defects to achieve better health and quality of life – and that is exactly what drives us every day."
Jürgen Ehlers | Managing Director DIZG |
German Institute for Cell and Tissue Replacement

Enable improved healing for people

Research and development take center stage, with the goal of offering people with severe tissue defects improved healing prospects. For this reason, the institute promotes tissue donation and continuously advances the diversity of allogeneic avital transplants through its own R&D department.

Exclusively Non-Profit Purposes

The institute pursues exclusively and directly non-profit purposes. Its objective is to support surgeons who require human tissue transplants for the treatment of tissue defects caused by illness or injury. The fundamental prerequisite for use must always be the surgeon’s assessment that the application of human tissue transplants is medically necessary.

Our Mission Statement

Valuing tissue donation and ensuring continuous quality improvement

The transplants provided by DIZG help preserve patients’ lives and improve their quality of life by minimizing pain and restoring mobility. Our actions, behavior, and language are always characterized by deep appreciation for tissue donation as an act of charity. Our goal is to continuously optimize the quality and organization of tissue donations.

The management and employees of DIZG always keep these principles in mind and apply them in their interactions with each other, as well as with customers, partners, and the media. A strong commitment to ethical and moral standards, along with corresponding expectations for our partners, forms the foundation of all actions taken by DIZG.

Top priority: safety

The safety of patients as transplant recipients is the highest priority at DIZG and takes precedence over all other interests. Equally important is the safety of DIZG employees and tissue donation partners. Every employee is aware of their responsibility to immediately report hazardous situations and identified safety risks to the responsible authorities, the relevant supervisor, or management. Suggestions for improving transplants in terms of their application safety and handling are always expressly welcomed.

Since its founding, approximately 868,000 transplants have been delivered infection-free.

Our Work Environment: Committed to Equality

We work in an environment that equally challenges and supports all employees. Gender equality is a matter of course for us. At DIZG, we adhere to the principle of not allowing any discrimination in our employment practices based on ethnic or national origin, gender, political beliefs, age, family circumstances, or disability. This principle applies both to applicants and employees alike.

For the qualification of our employees:
Training and further education measures

Every training or further education program that enhances employees’ skills and knowledge contributes to the overall success of the institute. As part of official training events, DIZG offers a range of educational and professional development topics for its employees. These topics cover everything from specific work procedures and safety issues to general knowledge about donation and transplantation.

Environmental Protection and Sustainability as a Consequence of Responsible Action

For DIZG, it is a fundamental commitment to use natural resources responsibly, produce safely, and minimize environmental impact as much as possible. Therefore, we consider comprehensive environmental protection, maximum occupational safety, high product quality, and optimal economic efficiency as equally important success factors in achieving our corporate goals.

Success in the areas of environmental protection and safety requires dedicated, competent, and responsible action from all employees of the institute. To ensure this, employees receive training and continuous education, as everyone must set an example for environmental protection and safety through their personal conduct.

The Knowledge of Helping Others Drives Us

We Are Committed to Providing Safe Transplants.

Milestones

1993
Foundation

Foundation of DIZG as a non-profit GmbH in Berlin, with head quarter in Berlin-Buch and potential processing facility in Leipzig

1994
EATB Membership

DIZG becomes a member of the EATB (European Association of Tissue
Banks) and obtains manufacturing authorization for allogeneic avital tissue
transplants. It consists of eight employees.

1999
Autologous cell cultures

DIZG receives permission to produce autologous cell cultures.

2000
Merger agreement

The merger agreement with BIOCON Inc. is signed. It also includes MTF, currently the largest tissue bank in the world.

2001
Relocation to IPW

Relocation to Innovation Park Wuhlheide, the allogeneic transplants will continue to be sterilized and aseptically processed in Leipzig.

2005
Issuance of pharmaceutical licenses § 21 AMG

Issuance of pharmaceutical licenses according to § 21 AMG
by PEI/BfArM for all DIZG transplants

2007
Fall

September: inauguration of our new production building in the Innovation
Park and closure of Leipzig’s location.

October: DIZG receives its manufacturing license for allogeneic transplants for its new site and becomes the only facility in Germany to have an authorization according to § 21 AMG for human acellular dermis.

2008
Cell sprayer

DIZG develops a cell sprayer as its first medical product for application of keratinocytes in second-degree burns treatment.

2010
Permanent approvals

Final and indefinite extension of approvals for allogeneic transplants as pharmaceuticals

2018
25th anniversary

25th Anniversary of DIZG (1993–2018)

2020
Employees/Cell Spray

DIZG employs more than 100 people and the handy Cell Spray replaces the cell sprayer.

2021
Fiberfill®/groundbreaking for new facility

Authorization for Fiberfill®, and the foundation for Facility 2025, DIZG’s new production facility, is laid.

2022
Topping-out ceremony "Facility 2025"

Topping-out ceremony for our 2,526 m² Facility 2025 for human bone and soft tissue processing.

2023
DIZG grows/30th anniversary and Shark Screw® for Germany

The DIZG continues to grow and employs 125 employees (March 01, 2024) and celebrates its 30th anniversary.

Germany-wide introduction of Shark Screw®

You might also be interested in:

Contact us

Get in touch now

For all inquiries regarding shipping, fees, and our transplants, our distribution team is happy to assist you.

Send us an email:

distribution@dizg.de